SITC Primer on Tumor Immunology and Cancer Immunotherapyâ„¢

The SITC 2015 Presentation Archive is supported through a generous contribution from AstraZeneca/MedImmune.

Access slide decks and video via the links in the schedule below.

= PDF of slides is available

= Presentation video is available

Program Schedule

Thursday, November 5, 2015

8 – 8:10 a.m.	Welcome & Introductions Willem W. Overwijk, PhD – University of Texas MD Anderson Cancer Center
Session I: Basic Immunology – A Brief Overview 2 AMA PRA Category 1 Credits™
8:10 – 8:45 a.m.	Introduction to Innate Immunity     Willem W. Overwijk, PhD – University of Texas MD Anderson Cancer Center
8:45 – 9:20 a.m.	Obstacles to Driving an Immune Response Margaret K. Callahan, MD, PhD – Memorial Sloan Kettering Cancer Center
9:20 – 9:55 a.m.	Overview of Adaptive Immunity     Jonathon Powell, MD, PhD – Johns Hopkins University
9:55 – 10:10 a.m.	Panel Questions & Answers
10:10 – 10:25 a.m.	Break
Session II: Treating Tumors with Passive Immunotherapy 2 AMA PRA Category 1 Credits™
10:25 – 10:30 a.m.	Session II Introduction
10:30 – 11:05 a.m.	Adoptive T Cell Therapy   Michel Sadelain, MD, PhD – Memorial Sloan Kettering Cancer Center
11:05 – 11:40 a.m.	Anti-Tumor Antibodies     Charles G. Drake, MD, PhD – Johns Hopkins University
11:40 – 12:15 p.m.	Dendritic Cells: Basic Biology and Therapeutic Use     A. Karolina Palucka, MD, PhD – The Jackson Laboratory for Genomic Medicine
12:15 – 12:30 p.m.	Panel Questions & Answers
12:30 – 1:30 p.m.	Lunch
Session III: Active Immunotherapy – Unleashing the Patient’s Own Immune System 1.5 AMA PRA Category 1 Credits™
1:30 – 1:35 p.m.	Session III Introduction
1:35 – 2:10 p.m.	Cancer Vaccines     Patrick Ott, MD, PhD – Dana-Farber Cancer Institute/Harvard Medical School
2:10 – 2:45 p.m.	Targeting Immune Checkpoints in Cancer Therapy: New Insights and Opportunities   Suzanne L. Topalian, MD – Johns Hopkins University
2:45 – 3 p.m.	Panel Questions & Answers
3 – 3:15 p.m.	Break
Session IV: Immune Monitoring – Figuring out How it All Works 1.75 AMA PRA Category 1 Credits™
3:15 – 3:20 p.m.	Session IV Introduction
3:20 – 3:55 p.m.	Monitoring of Cellular and Humoral Immune Responses in Tumor Immunotherapy   Sacha Gnjatic, PhD – Icahn School of Medicine at Mount Sinai
3:55 – 4:30 p.m.	Pre-Surgical Clinical Trial Design for Immune Monitoring     Sumit Subudhi, MD, PhD – University of Texas MD Anderson Cancer Center
4:30 – 4:45 p.m.	Panel Questions and Answers
4:45 – 5 p.m.	Closing Remarks Margaret K. Callahan, MD, PhD – Memorial Sloan Kettering Cancer Center